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A New View of Vitiligo: Looking at
Normal-Appearing Skin
Mauro Picardo1 and Emanuela Bastonini1
Debate over the pathogenesis of vitiligo is still ongoing among scientists, with
several hypotheses currently under consideration. The study by Wagner et al. in
this issue focuses on the role of E-cadherin-mediated cell adhesion in vitiliginous
epidermis under oxidative and mechanical stress. Their work highlights how
alterations in cell–cell adhesion across nonlesional melanocyte membranes in
patients with vitiligo argue for primary intrinsic defects in the melanocytes.
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Vitiligo, the most common disorder of
depigmentation, is an acquired disease
characterized by a progressive loss of
melanocytes from the epidermis and folli-
cular reservoir. New deﬁnition, assessment,
and treatment criteria have been proposed
for clinical research in vitiligo (Ezzedine
et al., 2012; Eleftheriadou et al., 2015).
Despite recent studies that have con-
tributed new knowledge about the disease,
understanding its pathogenesis remains a
major challenge. Although several hypoth-
eses have been proposed, an autoimmune
response against melanocytes remains the
leading candidate. Accordingly, genetic
defects in loci encoding immunoregulatory
proteins and melanocyte components that
mediate the immune targeting of melano-
cytes have been reported (Jin et al., 2012).
Nevertheless, recent evidence argues for
intrinsic metabolic defects in nonlesional
melanocytes, leading to intracellular oxida-
tive stress, as the primary intracellular signal
for melanocyte degeneration. Recognizing
that living cells are subjected to exo-
genously or endogenously produced reac-
tive oxygen species, elevated oxidative
stress may be the initial event that leads
to the activation of the antimelanocyte
immune responses in patients with genetic
predisposition to autoimmunity (Dell’Anna
and Picardo, 2006; Schallreuter et al.,
2012; Denat et al., 2014; Ezzedine et al.,
2015). Consistent with the idea that
increased oxidative stress and an impaired
ability to manage stress effectively are
hallmarks of vitiligo, is the observation
that melanocytes from nonlesional skin
show alterations of pathways leading to a
stress-induced premature senescence-
like phenotype (Bellei et al., 2013).
Nevertheless, the mechanisms of mela-
nocyte disappearance remain uncertain.
Harris et al. (2012) demonstrated that
depigmentation is accompanied by an
accumulation of autoreactive CD8+ cells
and local INF-γ production in the skin,
supporting an autoimmune hypothesis.
Still, plasmacytoid dendritic cells, which
are part of the perilesional cellular inﬁltrate
and the major IFN-α-producing cell
subset, may sustain the recruitment and
activation of T cells (Bertolotti et al., 2014).
In support of this mechanism, apoptosis in
vitiligo melanocytes has also been
demonstrated (Wu et al., 2013).
The paper by Wagner et al. (this issue,
2015) provides new insight into the loss of
melanocytes by demonstrating altered cell–
cell adhesion that, in turn, is linked to the
absence and discontinuous distributions of
E-cadherin in normal-appearing skin. E-cad-
herin is one member of a family of Ca2+-
dependent transmembrane proteins, and
it mediates melanocyte–keratinocyte inter-
actions in the epidermis. In vitiligo, its loss
from the membrane speciﬁcally affects
melanocytes, because usual levels aremuch
lower than in keratinocytes. Moreover,
B-catenin, the partner of E-cadherin in
regulating cell–cell adhesion, is similarly
absent or discontinuously distributed in
melanocyte membranes from nonlesional
skin of patients with vitiligo. Melanocyte
distribution in the basal layer of nonlesional
skin is altered. Although the total number of
melanocytes is similar to that of controls, in
vitiligo more melanocytes are detached
from the basal membrane and located in a
suprabasal location where they seem to be
more susceptible to apoptosis. Interestingly,
IL-1β expression is similar to that of control
skin, suggesting that alterations in cellular
adhesion cannot be attributed to previous
activation of an inﬂammatory process.
These data are in agreement with the
melanocytorrhagy hypothesis that has
been proposed as the primary event in
melanocytic detachment following a
mechanical trauma (Gauthier et al., 2003)
and with the reduced number of melano-
cytes in the basal layer of reconstructed
skin using melanocytes from subjects
without vitiligo (Cario-André et al., 2007).
However, in mice with E-cadherin-deﬁ-
cient melanocytes, depigmentation occurs
only after mechanical stress that is caused
by repeated brushing of tail skin and in a
model of reconstructed epidermis with
normal melanocytes after exposure to
H2O2 that leads to E-cadherin destabiliza-
tion. In skin biopsies from patients with
vitiligo, E-cadherin alterations are associated
with lipoperoxidative damage. Therefore,
persistent and widespread stress affecting
the distribution of E-cadherin across mela-
nocyte membranes in patients with vitiligo,
before the appearance of clinical lesions,
cause functional impairment, arguing for
primary defects in the melanocytes. In vivo
confocal microscopy in nonlesional skin of
patients with vitiligo have shown abnormal
distribution patterns of brightness at the
dermoepidermal junction, suggesting that
changes in light reﬂectance indexes corre-
latewith incomplete distributions of pigment
at the basal cell level (Ardigo et al., 2007).
Dissociation of melanocytes from the
basal membrane may be regulated by
growth factors and cytokines released by
epidermal and dermal cells. In melanoma
cells, hepatocyte growth factor and ET-1
downmodulate E-cadherin expression,
allowing melanocytes to dissociate from
keratinocytes and to migrate through inter-
cellular spaces (Haass and Herlyn, 2005).
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Recently, immunohistochemical examina-
tion of E-cadherin in tissue sam-
ples collected from patients with vitiligo,
after punch grafting, revealed that melano-
cytes from normally pigmented donor
sites may migrate toward lesional skin
and repopulate the depigmented areas
because of decreased E-cadherin expres-
sion (Kovacs et al., 2015). The mecha-
nisms that underly the activation of
melanocytes after punch grafting have not
been fully explained. Nevertheless, the
process might be regulated by epidermal
and dermal cells that should be able to
manage cell adhesion actively.
Therapeutic options for vitiligo are still
limited. Although somemechanisms under-
lying the interplay between oxidative stress
and immunity have been postulated
(Richmond et al., 2013), understanding
mechanisms that cause oxidative stress
could provide valuable information to
identify new therapeutic targets. The chal-
lenge will be to maintain cells metabo-
lically active as requirement for sustaining
the energy demand and coping with oxida-
tive stress. Moreover, the analysis has to be
extended to pigmented skin to both identify
early events in “silent” vitiligo melanocytes
and prevent the spread of the disease.
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Clinical Implications
● In vitiligo, all the skin is affected.
● Modiﬁcation of pigment distributions in the skin may be associated with
other alterations, such as defects in the epidermal barrier.
● Stabilization of the disease, by targeting nonlesional skin, is an additional
challenge for improving the beneﬁts of treatment.
● Full-body phototherapy may stabilize the disease by inducing the differentia-
tion of melanocytes, with consequent improvements in cell–cell adhesion.
● Counteracting extracellular and intracellular oxidative stress may con-
tribute to reducing melanocyte detachment and disease progression.
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EDA Fibronectin in Keloids Create a
Vicious Cycle of Fibrotic Tumor Formation
Rhiannon M. Kelsh1, Paula J. McKeown-Longo1 and Richard A.F. Clark2
During the early phase of wound healing, ﬁrst plasma ﬁbronectin (FN) and then in situ
FN are deposited at the site of injury. In situ FN––FN made by tissue cells at the injury
site––often contains an extra domain A (EDA) insert. Multiple wound-related signal
transduction pathways control the deposition of EDA FN, and the EDA insert can in
turn trigger pathways that induce inﬂammation, increased extracellular matrix
molecule deposition including FN and collagen, and activation of ﬁbroblasts. Together
these pathways can create a vicious cycle that leads to ﬁbrosis or keloid formation.
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